Clinical Benefit of Insulin Glargine 300 U/mL Among Patients with Type 2 Diabetes Mellitus Previously Uncontrolled on Basal or Premixed Insulin in Serbia: A Prospective, Observational, Single-Arm, Multicenter, Real-World Study

INTRODUCTION: Insulin glargine 300 U/mL (Gla-300) is a novel glargine formulation which shows slower and more prolonged absorption following subcutaneous administration in comparison to insulin glargine 100 U/mL. In this prospective, observational, single-arm, multicenter, real-world study conducted...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Diabetes Ther
Main Authors: Velojic-Golubovic, Milena, Ciric, Vojislav, Dimitrijevic, Marija, Kovic, Tijana, Mitic, Milica, Olujic, Biljana, Pevac, Natasa, Radenkovic, Sasa, Radojkovic, Danijela, Vukadinovic, Selena, Popovic, Djordje S.
Format: Artigo
Sprog:Inglês
Udgivet: Springer Healthcare 2021
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8266919/
https://ncbi.nlm.nih.gov/pubmed/34160790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-021-01074-2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker